Literature DB >> 23972060

Primary objective of study of sitagliptin in patients with ESRD on dialysis.

J C Arjona Ferreira, G T Golm, B J Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23972060     DOI： 10.1053/j.ajkd.2013.05.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  2 in total

1.  Characterization of Sitagliptin Use in Patients with Type 2 Diabetes and Chronic Kidney Disease by Cross-Sectional Analysis of a Medical Insurance Claims Database.

Authors:  Kimberly G Brodovicz; Yong Chen; Zhiwen Liu; Mary E Ritchey; Jane Liao; Samuel S Engel
Journal:  Diabetes Ther       Date:  2015-10-05       Impact factor: 2.945

2.  Evaluation of efficacy and safety of DPP-4 inhibitors for Chinese elderly patients with type 2 diabetes mellitus.

Authors:  Dong-Ni Yu; Lei Qiu; Shang-Yong Ning; Li-Xin Guo
Journal:  Diabetol Metab Syndr       Date:  2020-04-29       Impact factor: 3.320
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.